Atrion Corporation (NASDAQ:ATRI) Files An 8-K Submission of Matters to a Vote of Security Holders

Atrion Corporation (NASDAQ:ATRI) Files An 8-K Submission of Matters to a Vote of Security Holders

Story continues below

Item 5.07.

Submission of Matters to a Vote of Security
Holders.

On May 23, 2017, the Registrant held its 2017 annual meeting of
stockholders. Stockholders voted on the matters below.

1. Election of Directors. The nominees listed below
were elected to serve as directors until the 2020 annual
meeting of stockholders and until their successors are duly
elected and qualified, based on the following votes:
Director Votes For Votes Withheld Broker Non-Votes
Emile A Battat 1,435,513 73,342 222,482
Ronald N. Spaulding 1,438,025 70,830 222,482
2. Ratification of Appointment of Independent Registered
Public Accounting Firm.
The Registrants stockholders
ratified the appointment of Grant Thornton LLP as the
Registrants independent registered public accounting firm for
the year ending December 31, 2017, based on the following
votes:
Votes For Votes Against Abstentions Broker Non-Votes
1,724,063 2,117 5,157
3. Advisory Vote to Approve Executive Officer
Compensation
. The Registrants stockholders approved, on
an advisory basis, the compensation of the Registrants
executive officers, based on the following votes:
Votes For Votes Against Abstentions Broker Non-Votes
1,231,359 271,057 6,439 222,482
4. Advisory Vote on Frequency of the Advisory Vote to
Approve Executive Officer Compensation.
As reflected in
the votes set forth below, the Registrants stockholders
expressed a preference that the advisory vote to approve
executive officer compensation be held every year.
One Year Two Years Three Years Abstain Broker Non-Votes
1,116,386 388,839 3,254 222,482

Based on these results, and the Board of Directors prior
recommendation, the Board of Directors has determined to continue
to hold an advisory vote to approve executive officer
compensation on an annual basis (i.e., every year).


About Atrion Corporation (NASDAQ:ATRI)

Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety. It has developed a range of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in areas, such as anesthesia and oncology. Its cardiovascular product, MPS2 Myocardial Protection System (MPS2), is the system used in open-heart surgery that delivers fluids and medications, mixes critical drugs and controls temperature, pressure and other variables. Atrion is a manufacturer of specialized medical devices that disinfect contact lenses. Its other medical and non-medical product lines consist of instrumentation and associated disposables.

Atrion Corporation (NASDAQ:ATRI) Recent Trading Information

Atrion Corporation (NASDAQ:ATRI) closed its last trading session up +2.10 at 540.10 with 4,727 shares trading hands.

An ad to help with our costs